Stabilized HBc chimer particles as therapeutic vaccine for chronic hepatitis

Details for Australian Patent Application No. 2004216246 (hide)

Owner Lorantis Limited

Inventors Schmidt, Annette Elisabeth; Page, Mark; Friede, Martin; Stober, Detlef

Agent Griffith Hack

Pub. Number AU-B-2004216246

PCT Pub. Number WO2004/075836

Priority 10/372,076 21.02.03 US; 10/677,074 01.10.03 US

Filing date 20 February 2004

Wipo publication date 10 September 2004

Acceptance publication date 7 August 2008

International Classifications

C07K 14/02 (2006.01) Peptides having more than 20 amino acids

C12N 15/36 (2006.01) Mutation or genetic engineering

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

8 September 2005 PCT application entered the National Phase

  PCT publication WO2004/075836 Priority application(s): WO2004/075836

7 August 2008 Application Accepted

  Published as AU-B-2004216246

4 December 2008 Standard Patent Sealed

16 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004216247-Splanchnic nerve stimulation for treatment of obesity

2004216245-Methods for the treatment of renal cell carcinoma